A Randomized, Multicenter Open Label Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis.
Phase of Trial: Phase IV
Latest Information Update: 04 Jan 2017
At a glance
- Drugs Ciclosporin (Primary) ; Ciclosporin (Primary) ; Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms CYSIF
- 04 Jan 2017 Results assessing long term outcomes from patients with steroid-refractory acute severe ulcerative-colitis published in the Gut.
- 10 Oct 2012 Results published in the Lancet.
- 10 Oct 2012 Primary endpoint 'Treatment-failure-rate' has not been met.